You are viewing the site in preview mode

Skip to main content

Advertisement

Table 3 Assessment of service readiness for routine child immunization according to healthcare facility levels in the two selected divisions of Bangladesh

From: General service and child immunization-specific readiness assessment of healthcare facilities in two selected divisions in Bangladesh

Variables Rajshahi division (N = 28) Sylhet division (N = 31)
  Facilities with vaccine storage Facilities without vaccine storage Facilities with vaccine storage Facilities without vaccine storage
General characteristics
 Number of facilities [n] 4 24 5 26
 Public facility [n (%)] 4 (100.0) 22 (91.7) 5 (100.0) 21 (80.8)
 Area [n (%)]
  Rural 4 (100.0) 22 (91.7) 4 (80.0) 23 (88.5)
  Urban 0 (0.0) 2 (8.3) 1 (20.0) 3 (11.5)
 Vaccines and injection supplies are bundled [n (%)]
  No 0 (0.0) 0 (0.0) 0 (0.0) 4 (15.4)
  Yes, only pick up 4 (100.0) 24 (100.0) 2 (40.0) 7 (26.9)
  Yes, both 0 (0.0) 0 (0.0) 3 (60.0) 14 (53.8)
 Service days per month [Mean (SD)] 7 (5.0) 4 (7.8) 21 (7.3) 2 (2.6)
 Hours of service on a typical day [Mean (SD)] 4 (2.5) 5 (0.6) 6 (0.5) 6 (0.8)
 Staffs involved in vaccination [Mean (SD)] 2 (1.0) 2 (0.4) 1 (0.5) 2 (0.6)
 Outreach services available [n (%)] 4 (100.0) 0 (0.0) 4 (80.0) 0 (0.0)
Staff and training
 Guidelines for EPI % 4 (100.0) 0 (0.0) 2 (40.0) 0 (0.0)
 Staff trained in EPI % 4 (100.0) 24 (100.0) 5 (100.0) 25 (96.2)
Equipment
 Cold box/vaccine carrier with ice packs [n (%)] 4 (100.0) 0 (0.0) 5 (100.0) 0 (0.0)
 Refrigerator [n (%)] 4 (100.0) 0 (0.0) 5 (100.0) 0 (0.0)
 Sharp container [n (%)] 1 (25.0) 2 (8.3) 1 (20.0) 4 (15.4)
 Single use- standard disposable or auto-disable syringes [n (%)] 4 (100.0) 24 (100.0) 5 (100.0) 25 (96.2)
 Continuous temperature monitoring device in refrigerator [n (%)] 4 (100.0) 0 (0.0) 4 (80.0) 0 (0.0)
 Energy source and power supply for vaccine refrigerator [n (%)] 4 (100.0) 0 (0.0) 4 (80.0) 0 (0.0)
 Immunization cards [n (%)] 4 (100.0) 22 (91.7) 4 (80.0) 18 (69.2)
Medicines and commodities
 Measles & Rubella vaccine [n (%)] 4 (100.0) 4 (16.7) 5 (100.0) 1 (3.8)
 Penta (DPT + Hib + HepB) vaccine [n (%)] 4 (100.0) 4 (16.7) 5 (100.0) 1 (3.8)
 Polio vaccine [n (%)] 4 (100.0) 4 (16.7) 5 (100.0) 1 (3.8)
 BCG vaccine [n (%)] 4 (100.0) 4 (16.7) 5 (100.0) 0 (0.0)
 PCV [n (%)] 4 (100.0) 3 (12.5) 3 (60.0) 1 (3.8)
IPV [n (%)] 3 (75.0) 2 (8.3) 5 (100.0) 1 (3.8)
 Stock-outs in the past 3 months
 Measles & Rubella vaccine [n (%)] 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 Penta (DPT + Hib + HepB) vaccine [n (%)] 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 Polio vaccine [n (%)] 0(0.0) 0(0.0) 1(20.0) 0(0.0)
 BCG vaccine [n (%)] 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 PCV [n (%)] 0(0.0) 0(0.0) 0(0.0) 0(0.0)
 IPV [n (%)] 3(75.0) 0(0.0) 0(0.0) 0(0.0)
  1. BCG Bacillus Calmette-Guérin, EPI Expanded Program on Immunization, IPV Inactivated Polio Vaccine, PCV Pneumococcal Conjugate Vaccine, SD Standard deviation